Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000093751-24-000892
Filing Date
2024-10-18
Accepted
2024-10-18 12:29:43
Documents
1

Document Format Files

Seq Description Document Type Size
1 Vir_Biotechnology_Inc.htm SC 13G/A 53989
  Complete submission text file 0000093751-24-000892.txt   55974
Mailing Address 1 CONGRESS STREET SUITE 1 BOSTON MA 02114
Business Address 1 CONGRESS STREET SUITE 1 BOSTON MA 02114 617 786-3000
STATE STREET CORP (Filed by) CIK: 0000093751 (see all company filings)

EIN.: 042456637 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6022 State Commercial Banks
(CF Office: 02 Finance)

Mailing Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158
Business Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Subject) CIK: 0001706431 (see all company filings)

EIN.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91177 | Film No.: 241379652
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)